Valens director Zilka Yahal files Form 3 holdings
Valens Semiconductor Ltd. director Zilka Yahal has filed an initial Form 3 showing existing equity holdings in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Valens Semiconductor Ltd. director Zilka Yahal has filed an initial Form 3 showing existing equity holdings in the company. The filing reports multiple blocks of Ordinary Shares held directly, including one position of 905,021 shares, along with several grants of stock options (rights to buy Ordinary Shares) at exercise prices ranging from $1.66 to $7.58 per share, with expirations between 2029 and 2033. Footnotes explain that some shares were issued upon vesting of previously granted RSUs, some were received as a pro‑rata in‑kind distribution from a venture capital fund, and certain RSUs and options vest in four equal quarterly portions starting from the first anniversary of the January 15, 2026 grant date, subject to continued service.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Ordinary Shares | -- | -- | -- |
| Holding | Ordinary Shares | -- | -- | -- |
| Holding | Ordinary Shares | -- | -- | -- |
Footnotes (5)
- F1. These shares were issued upon vesting of previously granted RSU's
- F2. The reported securities were received by the Reporting Person as a pro-rata in-kind distribution from a venture capital fund in which the Reporting Person serves as a GP. The distribution was made without consideration and represents the Reporting Person's allocable share of the fund's holdings
- F3. The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Valens Semiconductor Ltd. (the "Company"). The units vest in four Equal portions on a quarterly basis within 90 days, 180 days, 270 days of the first anniversary of the date of grant (01/15/2026), subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.
- F4. The Stock Options are Fully vested and immediately exercisable
- F5. The options vest in four Equal portions on a quarterly basis within 90 days, 180 days, 270 days of the first anniversary of the date of grant (01/15/2026), subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Valens Semiconductor (VLN) director Zilka Yahal report on this Form 3?
Are there any buy or sell transactions in Valens Semiconductor (VLN) director Zilka Yahal’s Form 3?
What stock options does Zilka Yahal hold in Valens Semiconductor (VLN)?
What are the vesting terms for Zilka Yahal’s RSUs and options in Valens Semiconductor (VLN)?
Are any of Zilka Yahal’s Valens Semiconductor (VLN) options already exercisable?
AI-generated analysis. How Rhea-AI works. Not financial advice.
